News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,370 Results
Type
Article (39004)
Company Profile (277)
Press Release (645089)
Section
Business (203849)
Career Advice (1987)
Deals (35359)
Drug Delivery (85)
Drug Development (80779)
Employer Resources (168)
FDA (16085)
Job Trends (14801)
News (344503)
Policy (32431)
Tag
Academia (2530)
Alliances (49054)
Alzheimer's disease (1219)
Approvals (16007)
Artificial intelligence (124)
Bankruptcy (352)
Best Places to Work (11505)
Biotechnology (196)
Breast cancer (114)
Cancer (995)
Cardiovascular disease (83)
Career advice (1657)
Cell therapy (213)
Clinical research (64050)
Collaboration (346)
Compensation (184)
COVID-19 (2523)
C-suite (86)
Data (978)
Diabetes (145)
Diagnostics (6116)
Earnings (84569)
Employer resources (146)
Events (109204)
Executive appointments (267)
FDA (16558)
Funding (309)
Gene therapy (159)
GLP-1 (569)
Government (4321)
Healthcare (18662)
Infectious disease (2604)
Inflammatory bowel disease (103)
Interviews (308)
IPO (16279)
Job creations (3623)
Job search strategy (1415)
Layoffs (410)
Legal (7851)
Lung cancer (159)
Manufacturing (160)
Medical device (13158)
Medtech (13163)
Mergers & acquisitions (19125)
Metabolic disorders (381)
Neuroscience (1470)
NextGen Class of 2024 (6497)
Non-profit (4463)
Northern California (1345)
Obesity (223)
Opinion (177)
Patents (96)
People (56174)
Phase I (19889)
Phase II (28205)
Phase III (21046)
Pipeline (328)
Postmarket research (2553)
Preclinical (8455)
Radiopharmaceuticals (234)
Rare diseases (196)
Real estate (5888)
Regulatory (21468)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1191)
Startups (3560)
United States (12522)
Vaccines (544)
Weight loss (164)
Date
Today (174)
Last 7 days (974)
Last 30 days (3373)
Last 365 days (35391)
2024 (31474)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (189)
Asia (37065)
Australia (6044)
California (3018)
Canada (1217)
China (234)
Colorado (130)
Connecticut (140)
Europe (79348)
Florida (420)
Georgia (108)
Illinois (329)
Indiana (188)
Kansas (96)
Maryland (549)
Massachusetts (2421)
Michigan (149)
Minnesota (260)
New Jersey (886)
New York (893)
North Carolina (676)
Northern California (1345)
Ohio (129)
Pennsylvania (791)
South America (1091)
Southern California (1191)
Texas (416)
Utah (84)
Washington State (340)
684,370 Results for "engene inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
enGene to Present at the Jefferies Global Healthcare Conference
enGene Holdings Inc. today announced that Jason Hanson, Chief Executive Officer, will present a corporate overview at the Jefferies Global Healthcare Conference in New York City, on June 5, 2024, at 12:30 p.m. ET.
May 29, 2024
·
1 min read
Press Releases
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
November 6, 2024
·
1 min read
Press Releases
enGene Announces $60 Million Private Placement Financing
October 28, 2024
·
5 min read
Business
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”) today announced its financial results for the first quarter ended January 31, 2024.
March 11, 2024
·
9 min read
Business
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings and Singapore Medical Incorporation.
June 6, 2024
·
3 min read
Business
enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
enGene Holdings Inc., a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer, announced the election of Paul Hastings and Wouter Joustra as new members of its Board of Directors at the Company’s 2024 annual meeting of shareholders.
May 15, 2024
·
8 min read
enGene To Present at the Leerink Partners Global Biopharma Conference
enGene Holdings Inc. announced that Jason Hanson, Chief Executive Officer, will present at the Leerink Partners Global Biopharma Conference in Miami, FL on March 13, 2024, at 8:40 a.m. ET.
March 5, 2024
·
1 min read
enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting
enGene Holdings Inc. (Nasdaq: ENGN) or (“enGene” or the “Company”) today announced an oral presentation at the American Urology Association (AUA) 2024 Annual Meeting being held May 3-6, 2024 in San Antonio, Texas.
May 2, 2024
·
5 min read
Press Releases
enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - October 22, 2024
October 23, 2024
·
2 min read
Press Releases
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 1, 2024
·
2 min read
1 of 68,437
Next
